Vectura Group PLC (VEC.L)

VEC.L

About

Vectura Group plc (Vectura) is a developer of therapies principally for the treatment of respiratory diseases. The Company is engaged in developing treatments for respiratory diseases. Vectura’s products target diseases, such as asthma and chronic obstructive pulmonary disease (COPD). The Company’s pharmaceutical business... (more)

Buy/Sell

» Analyst Consensus

Overall

Beta:	0.21
Market Cap (Mil.):	£271.58
Shares Outstanding (Mil.):	335.29
Dividend:	--
Yield (%):	--

Financials

	VEC.L	Industry	Sector
P/E (TTM):	--	30.37	30.65
EPS (TTM):	-0.02	--	--
ROI:	-4.25	19.50	18.83
ROE:	-4.30	20.27	19.74

Latest News about VEC.L

BRIEF-Vectura says trading in line

LONDON, Feb 13 - Vectura Group PLC : * Financial performance from 1 October 2012 to date has been in line with the

13 Feb 2013

» More VEC.L News

Earnings vs. Estimates

Analyst Research Reports

Report Title	Price
Thomson Reuters Stock Report - VECTURA GROUP PLC (VEC-LN) Provider: Thomson Reuters Stock Report	$25.00 Buy
Vectura Group plc Provider: Datamonitor	$175.00 Buy
Vectura Group PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider: Reuters Investment Profile	$20.00 Buy
Wright Investors Service Comprehensive Report for Vectura Group PLC Provider: Wright Reports	$460.00 Buy
VEC.L - Event Transcript of Vectura Group PLC conference call, May 21, 2013 / 4:30AM ET Provider: Thomson Reuters StreetEvents	$75.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.